Wells Fargo & Company MN grew its position in shares of Agilent Technologies Inc (NYSE:A) by 5.8% in the 4th quarter, Holdings Channel reports. The firm owned 2,311,198 shares of the medical research company’s stock after acquiring an additional 126,696 shares during the quarter. Wells Fargo & Company MN’s holdings in Agilent Technologies were worth $154,781,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the business. Dupont Capital Management Corp acquired a new stake in shares of Agilent Technologies during the 3rd quarter worth approximately $101,000. Front Row Advisors LLC acquired a new stake in shares of Agilent Technologies during the 4th quarter worth approximately $106,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Agilent Technologies during the 3rd quarter worth approximately $213,000. Cannell Peter B & Co. Inc. acquired a new stake in shares of Agilent Technologies during the 3rd quarter worth approximately $215,000. Finally, First Allied Advisory Services Inc. acquired a new stake in shares of Agilent Technologies during the 3rd quarter worth approximately $225,000.
Shares of Agilent Technologies Inc (NYSE:A) opened at $71.97 on Monday. Agilent Technologies Inc has a 52-week low of $50.58 and a 52-week high of $75.00. The company has a debt-to-equity ratio of 0.40, a current ratio of 3.23 and a quick ratio of 2.78. The stock has a market cap of $23,225.96, a price-to-earnings ratio of 28.79, a P/E/G ratio of 2.41 and a beta of 1.28.
Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 14th. The medical research company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.08. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.16 billion. Agilent Technologies had a net margin of 4.25% and a return on equity of 17.70%. During the same quarter last year, the firm posted $0.53 EPS. equities analysts forecast that Agilent Technologies Inc will post 2.67 earnings per share for the current year.
A has been the subject of several recent analyst reports. Robert W. Baird reaffirmed a “buy” rating and set a $76.00 price objective on shares of Agilent Technologies in a research report on Thursday, January 18th. Barclays reaffirmed a “buy” rating and set a $74.00 price objective on shares of Agilent Technologies in a research report on Monday, January 8th. Deutsche Bank set a $75.00 price target on shares of Agilent Technologies and gave the company a “buy” rating in a research report on Tuesday, November 21st. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price target for the company in a research report on Tuesday, October 31st. Finally, Cowen reissued a “hold” rating and issued a $70.00 price target on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Five equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $70.98.
In other Agilent Technologies news, CEO Michael R. Mcmullen sold 21,850 shares of Agilent Technologies stock in a transaction on Monday, January 29th. The shares were sold at an average price of $75.00, for a total transaction of $1,638,750.00. Following the transaction, the chief executive officer now directly owns 324,687 shares of the company’s stock, valued at approximately $24,351,525. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Mark Doak sold 4,154 shares of Agilent Technologies stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $67.00, for a total transaction of $278,318.00. Following the transaction, the vice president now directly owns 68,270 shares in the company, valued at $4,574,090. The disclosure for this sale can be found here. Insiders have sold a total of 175,029 shares of company stock worth $12,349,106 over the last ninety days.
WARNING: This piece was posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.thelincolnianonline.com/2018/02/19/wells-fargo-company-mn-has-154-78-million-holdings-in-agilent-technologies-inc-a.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.